WuXi Biologics (Cayman) Inc.

OTCPK:WXIB.F Stock Report

Market Cap: US$9.2b

WuXi Biologics (Cayman) Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:WXIB.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Nov 24SellUS$172,788Weichang ZhouIndividual91,490US$1.89
20 Nov 24SellUS$561,403Zhisheng ChenIndividual297,258US$1.89
24 Jun 24BuyUS$2,141,838Ge Li And Ning Zhao Family Foundation, Endowment ArmCompany1,445,000US$1.48
21 Jun 24BuyUS$1,490,938Ge Li And Ning Zhao Family Foundation, Endowment ArmCompany1,000,000US$1.49
20 Jun 24BuyUS$305,413Ge Li And Ning Zhao Family Foundation, Endowment ArmCompany200,000US$1.53
12 Jun 24SellUS$140,672Weichang ZhouIndividual95,919US$1.47
12 Jun 24SellUS$850,918Zhisheng ChenIndividual580,209US$1.47
16 May 24SellUS$82,267,702JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany44,283,850US$1.86
13 May 24BuyUS$63,359,908JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany34,381,199US$1.84
28 Mar 24BuyUS$1,473,873Wuxi Biologics Holdings LimitedCompany831,000US$1.77
27 Mar 24BuyUS$432JP Morgan Asset ManagementCompany247US$1.75
27 Mar 24BuyUS$28,860JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany16,500US$1.75
27 Mar 24BuyUS$5,949,815JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany3,401,667US$1.75
27 Mar 24SellUS$15,562JP Morgan Asset ManagementCompany8,897US$1.75
27 Mar 24SellUS$6,122JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany3,500US$1.75
26 Mar 24SellUS$9,526,820JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany5,465,114US$1.74
19 Mar 24SellUS$31,507,098JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany17,602,783US$1.79
15 Mar 24BuyUS$41,368,375JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany21,989,717US$1.88
08 Mar 24BuyUS$1,864,833JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany831,114US$2.24
08 Mar 24SellUS$43,828JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany19,533US$2.24
08 Mar 24SellUS$12,925,306JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany5,760,518US$2.24
06 Mar 24SellUS$32,079,959JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany11,851,005US$2.71
04 Mar 24BuyUS$332J.P. Morgan Private Wealth Advisors LLCCompany126US$2.63
04 Mar 24BuyUS$36,836JP Morgan Asset ManagementCompany14,000US$2.63
04 Mar 24BuyUS$71,042JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany27,000US$2.63
04 Mar 24BuyUS$46,387,990JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany17,630,196US$2.63
04 Mar 24SellUS$38,152JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany14,500US$2.63
01 Mar 24SellUS$9,929,222JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany4,124,046US$2.41
28 Feb 24BuyUS$13,366,932JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany5,541,524US$2.41
26 Feb 24SellUS$45,012,656JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany18,636,736US$2.42
02 Feb 24BuyUS$94,296,631JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany41,742,218US$2.26
26 Jan 24BuyUS$41,389,023BlackRock, Inc.Company10,996,500US$3.76
24 Jan 24BuyUS$19,227,201Ge Li And Ning Zhao Family Foundation, Endowment ArmCompany5,235,500US$3.67
23 Jan 24SellUS$20,382,963BlackRock, Inc.Company5,595,500US$3.64
17 Jan 24BuyUS$387,276Kenneth Walton HitchnerIndividual100,000US$3.87
17 Jan 24BuyUS$99,672Jackson TaiIndividual25,700US$3.88
28 Dec 23SellUS$36,150,029JP Morgan Asset ManagementCompany9,870,129US$3.66

Insider Trading Volume

Insider Buying: WXIB.F insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of WXIB.F?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders14,902,4750.363%
Private Companies584,191,13314.2%
Institutions1,444,819,10535.2%
General Public2,060,681,20250.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 41.82% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.2%
Wuxi Biologics Holdings Limited
584,191,133US$1.3b0%no data
4.44%
BlackRock, Inc.
182,282,845US$409.7m0.03%0.01%
3.42%
The Vanguard Group, Inc.
140,503,614US$315.8m0.51%no data
2.19%
Baillie Gifford & Co.
89,936,386US$202.2m-1.26%0.09%
1.64%
Norges Bank Investment Management
67,514,160US$151.8m0%0.01%
1.5%
Bosera Asset Management Co., Ltd.
61,567,500US$138.4m0%0.59%
1.38%
State Street Global Advisors, Inc.
56,446,260US$126.9m0.22%no data
1.36%
GF Fund Management Co., Ltd.
55,921,000US$125.7m0%0.24%
1.36%
Schroder Investment Management (Hong Kong) Ltd.
55,708,500US$125.2m0%0.7%
1.31%
JP Morgan Asset Management
53,690,945US$120.7m0%0.01%
1.22%
JPMorgan Chase & Co, Brokerage and Securities Investments
50,063,659US$112.5m0%0.05%
0.98%
Dimensional Fund Advisors LP
40,119,013US$90.2m-0.36%0.01%
0.79%
China Asset Management Co. Ltd.
32,498,754US$73.0m-0.41%0.07%
0.77%
Zhong Ou Fund Management Co., Ltd
31,689,669US$71.2m0%0.26%
0.75%
China Merchants Fund Management Company Ltd.
30,742,086US$69.1m0%0.29%
0.71%
UBS Asset Management AG
29,038,611US$65.3m14.4%0.01%
0.54%
Franklin Resources, Inc.
22,312,644US$50.2m0.36%0.02%
0.53%
Hongde Fund Management Co., Ltd.
21,860,649US$49.1m0%1.09%
0.48%
Harvest Fund Management Co. Ltd.
19,505,000US$43.8m0%0.09%
0.42%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
17,047,925US$38.3m-8.7%0.01%
0.4%
Geode Capital Management, LLC
16,352,676US$36.8m-5.91%no data
0.39%
Schroder Investment Management (Singapore) Ltd.
16,043,500US$36.1m0%0.21%
0.35%
Zhisheng Chen
14,189,015US$31.9m-0.43%no data
0.34%
Amundi Asset Management SAS
13,799,945US$31.0m1.38%0.01%
0.32%
Hang Seng Investment Management Limited
13,319,755US$29.9m0%0.29%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 05:30
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

WuXi Biologics (Cayman) Inc. is covered by 54 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Linda LuBOCI Research Ltd.
Wai Chak YuenBOCI Research Ltd.
Bo LiBofA Global Research